Bristol Myers Squibb to Participate in Bank of America Securities 2022 Healthcare Conference Pharmaceutical Investing
Merck to Participate in Bank of America Securities 2022 Healthcare Conference Life Science Investing News
ROSEN, A TOP RANKED FIRM, Encourages Aurinia Pharmaceuticals Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - AUPH Pharmaceutical Investing
ROSEN, RESPECTED INVESTOR COUNSEL, Encourages AbbVie Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - ABBV Pharmaceutical Investing
Important Shareholder Reminder: Kessler Topaz Meltzer & Check, LLP Reminds AbbVie, Inc. Shareholders of Deadline in Securities Fraud Class Action Lawsuit Pharmaceutical Investing
CLASS ACTION UPDATE for ABBV, AUPH and LICY: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders Pharmaceutical Investing
Bausch + Lomb Presents Data from Second Pivotal Phase 3 Trial of Investigational Treatment NOV03 at the Association for Research in Vision and Ophthalmology Annual Meeting Pharmaceutical Investing
AUPH ALERT: The Klein Law Firm Announces a Lead Plaintiff Deadline of June 14, 2022 in the Class Action Filed on Behalf of Aurinia Pharmaceuticals Inc. Limited Shareholders Pharmaceutical Investing
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Playstudios, Twitter, Aurinia, and Stronghold and Encourages Investors to Contact the Firm Pharmaceutical Investing
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Volta, Embark, Lucid, and AbbVie and Encourages Investors to Contact the Firm Pharmaceutical Investing
Aurinia Pharmaceuticals Inc. CLASS ACTION Alert: Wolf Haldenstein Adler Freeman & Herz LLP announces that a securities class action lawsuit has been filed in the United States District Court for the Eastern District of New York against Aurinia Pharmaceuticals Inc. Pharmaceutical Investing
